Clinical Trials

NCT05438043 | ACTIVE_NOT_RECRUITING | PHASE3

213 participants

A Study of Daratumumab

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-12-15

Completion:

2029-01-31

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05432284 | NOT_YET_RECRUITING | PHASE1

32 participants

Behavioral Pharmacology of THC and Beta-Myrcene

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2027-07-31

Completion:

2028-11-30

Conditions

• Cannabis Use

Interventions

• DRUG

No Results Yet

NCT05424822 | ACTIVE_NOT_RECRUITING | PHASE1

167 participants

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-18

Completion:

2025-10-31

Conditions

• Lymphoma, Non-Hodgkin
• Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

• DRUG

No Results Yet

NCT05421663 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

166 participants

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-12

Completion:

2028-12-29

Conditions

• Lymphoma, Non-Hodgkin
• Lymphoma, B-Cell
• Lymphoma, Large B-Cell, Diffuse

Interventions

• BIOLOGICAL

No Results Yet

NCT05393661 | ACTIVE_NOT_RECRUITING

2000 participants

Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2017-01-01

Completion:

2030-12-31

Conditions

• Stroke, Acute
• Gait, Hemiplegic

Interventions

• OTHER

No Results Yet

NCT05388669 | ACTIVE_NOT_RECRUITING | PHASE3

418 participants

A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-05

Completion:

2024-01-03

Conditions

• Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT05384561 | RECRUITING | NA

70 participants

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-05-31

Completion:

2027-09-30

Conditions

• Hyposmia
• COVID-19
• Parosmia
• Anosmia
• SARS-CoV-2 Infection

Interventions

• OTHER

No Results Yet

NCT05382559 | RECRUITING | PHASE1

681 participants

A Study of ASP3082 in Adults With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-06-08

Completion:

2028-12-31

Conditions

• Solid Tumor

Interventions

• DRUG

No Results Yet

NCT05372640 | RECRUITING | PHASE1

45 participants

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2023-08-10

Completion:

2027-06-07

Conditions

• Anatomic Stage III Breast Cancer AJCC v8
• Anatomic Stage IV Breast Cancer AJCC v8
• Metastatic Breast Carcinoma
• Metastatic Malignant Solid Neoplasm
• Metastatic NUT Carcinoma
• Unresectable Breast Carcinoma
• Unresectable Malignant Solid Neoplasm
• Unresectable NUT Carcinoma

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05364372 | COMPLETED | NA

187 participants

SMLI With Hispanic Cancer Survivors and Caregivers

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-25

Completion:

2026-06-17

Conditions

• Cancer Survivors
• Cancer

Interventions

• BEHAVIORAL

No Results Yet

NCT05355701 | RECRUITING | PHASE1

267 participants

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-07-05

Completion:

2028-04-23

Conditions

• Melanoma
• Non-Small-Cell Lung Cancer
• Thyroid Cancer
• Glioma
• Advanced Colorectal Cancer (Part 1)

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT05347095 | ACTIVE_NOT_RECRUITING | PHASE3

288 participants

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-09-27

Completion:

2027-03-25

Conditions

• Fistulizing Crohns Disease
• Perianal Crohns Disease

Interventions

• DRUG

No Results Yet

NCT05327114 | RECRUITING | PHASE2/PHASE3

201 participants

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-09-23

Completion:

2027-05-14

Conditions

• Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

• DRUG

No Results Yet

NCT05316155 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

235 participants

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-04-11

Completion:

2028-03-30

Conditions

• Non-Muscle Invasive Bladder Neoplasms

Interventions

• DRUG

No Results Yet

NCT05313256 | COMPLETED | PHASE2/PHASE3

65 participants

Quick Epidural Top-up With Alkalinized Lidocaine for Emergent Caesarean Delivery

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-07-14

Completion:

2024-07-08

Conditions

• Obstetric Labor Complications

Interventions

• DRUG

No Results Yet

NCT05304767 | COMPLETED | PHASE3

290 participants

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-03-07

Completion:

2026-03-25

Conditions

• Schizophrenia

Interventions

• DRUG

No Results Yet

NCT05303467 | RECRUITING | PHASE1

36 participants

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-07-30

Completion:

2026-10-31

Conditions

• Glioblastoma Multiforme
• Recurrent Glioblastoma

Interventions

• DEVICE

No Results Yet

NCT05291091 | ACTIVE_NOT_RECRUITING | PHASE2

244 participants

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-11-10

Completion:

2026-09-30

Conditions

• Becker Muscular Dystrophy

Interventions

• DRUG

No Results Yet

NCT05283421 | RECRUITING | NA

150 participants

Improving Diagnostics in Cervical Dysplasia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2023-08-23

Completion:

2026-08-01

Conditions

• Cervical Cancer

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05279027 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

6 participants

Zr89 + PET Companion Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-03-08

Completion:

2026-07-31

Conditions

• Melanoma (Skin)

Interventions

• DRUG

No Results Yet

NCT05274425 | ACTIVE_NOT_RECRUITING

683 participants

A 24-week rPMS Study in Real-world Setting for Enerzair

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2022-05-09

Completion:

2026-12-23

Conditions

• Asthma

Interventions

• OTHER

No Results Yet

NCT05265273 | RECRUITING | PHASE2/PHASE3

12 participants

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-07-20

Completion:

2027-06-30

Conditions

• Myasthenia Gravis

Interventions

• DRUG

No Results Yet

NCT05242484 | ACTIVE_NOT_RECRUITING | PHASE2

577 participants

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-09-19

Completion:

2025-05-15

Conditions

• Colitis, Ulcerative

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT05217446 | ACTIVE_NOT_RECRUITING | PHASE2

108 participants

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-07-11

Completion:

2026-06-19

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT05213598 | RECRUITING

100 participants

Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2022-09-07

Completion:

2051-06-30

Conditions

• Congenital Heart Disease

No Results Yet

NCT05203939 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

22 participants

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-01-24

Completion:

2027-03-31

Conditions

• Retinitis Pigmentosa
• Leber Congenital Amaurosis

Interventions

• DRUG

No Results Yet

NCT05179876 | RECRUITING | PHASE3

280 participants

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-05-04

Completion:

2027-01-31

Conditions

• Hypertension, Pulmonary

Interventions

• DRUG

No Results Yet

NCT05179538 | ACTIVE_NOT_RECRUITING | NA

120 participants

Genetic and Cognitive Predictors of Aphasia Treatment Response

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-10-23

Completion:

2026-07-01

Conditions

• Aphasia

Interventions

• BEHAVIORAL

No Results Yet

NCT05169333 | RECRUITING

250000 participants

The Oxford Risk Factors And Non-Invasive Imaging Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2016-02-23

Completion:

2030-02-28

Conditions

• Cardiovascular Diseases
• Cardiovascular Risk Factors

No Results Yet

NCT05164471 | TERMINATED | PHASE1/PHASE2

6 participants

Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-12-06

Completion:

2023-05-31

Conditions

• Hemophilia B

Interventions

• GENETIC

Results Available

NCT05163171 | COMPLETED

122 participants

Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2022-01-10

Completion:

2022-07-20

Conditions

• Addiction
• Violence, Domestic

Interventions

• OTHER

No Results Yet

NCT05160948 | COMPLETED

105 participants

Change in Knowledge After Receiving Personal Air Pollution Results

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2021-11-10

Completion:

2022-11-10

Conditions

• Environmental Exposure

Interventions

• OTHER

Results Available

NCT05157477 | RECRUITING | NA

90 participants

Targeting the Sensory Disturbance in Autism Spectrum Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-06-17

Completion:

2027-12-31

Conditions

• Autistic Disorders Spectrum

Interventions

• BEHAVIORAL

No Results Yet

NCT05138133 | ACTIVE_NOT_RECRUITING | PHASE3

363 participants

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-02-15

Completion:

2027-02-23

Conditions

• Lupus Nephritis

Interventions

• DRUG

No Results Yet

NCT05130788 | COMPLETED | NA

150 participants

WeChat Quit Coach Pilot Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-02-10

Completion:

2025-01-15

Conditions

• Smoking Cessation

Interventions

• BEHAVIORAL
• DRUG

Results Available

NCT05092269 | ACTIVE_NOT_RECRUITING | PHASE3

159 participants

A Long-term Extension Study of Ustekinumab in Pediatric Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-10-18

Completion:

2027-09-29

Conditions

• Crohn Disease
• Colitis, Ulcerative
• Arthritis, Psoriatic

Interventions

• DRUG

No Results Yet

NCT05090033 | COMPLETED

103 participants

Characterizing the Use of Ofatumumab in a Real World Setting

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2022-12-08

Completion:

2026-02-06

Conditions

• Relapsing Multiple Sclerosis

Interventions

• OTHER

No Results Yet

NCT05083182 | COMPLETED | PHASE3

48 participants

A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-30

Completion:

2026-01-12

Conditions

• Arthritis, Juvenile

Interventions

• DRUG

No Results Yet

NCT05067283 | RECRUITING | PHASE1

830 participants

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-12-17

Completion:

2030-02-25

Conditions

• Advanced Solid Tumors

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT05063565 | ACTIVE_NOT_RECRUITING | PHASE2

100 participants

TheraSphere With Durvalumab and Tremelimumab for HCC

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2023-11-03

Completion:

2027-06-30

Conditions

• Hepatocellular Carcinoma

Interventions

• DEVICE
• DRUG

No Results Yet